Together with an earlier study [25], our results confirm that osteosarcoma cells depend upon active GSK- 3β for their survival and proliferation, thus highlighting the potential benefit of targeting GSK-3β for the treatment of osteosarcoma. Here, GSK3B is linked to osteosarcoma.